A Focus on the First 1,000 Days
Starting at conception, the health of both mother and child are of utmost importance. At Astarte Medical, we view the first 1,000 days as a window of opportunity to deliver solutions that allow hospitals and clinical teams to standardize care protocols and customize treatment plans, at a time that has a profound impact on long-term health.
These first 1,000 days are especially critical for preterm infants, who are facing significant challenges, which include:
Growth
Failure
Allergy, Asthma
and Obesity
Neurodevelopmental
Delays or Disabilities
Our NICUtrition Platform
Core to Astarte Medical is our comprehensive and proprietary dataset, which integrates feeding protocols, microbiome profiles and clinical information. Our NICUtrition® suite of products provides actionable information in real time to hospitals and clinical teams, enabling them to standardize care protocols, and customize treatment plans by quantifying preterm infant gut health.
About Astarte Medical
Led by a distinguished team and world-class advisors in neonatology, nutrition and microbiome, Astarte Medical is the only precision medicine company using software and predictive analytics to improve outcomes during the first 1,000 days of life, with an initial focus on preterm infants.
Featured News
The story of two women who’ve raised more than $6 million to start their own ‘fem tech’ company for women and children’s health
Monitoring devices for preterm infants haven’t changed much since the ’60s. But they’re about to.
Astarte Medical Appoints Giulia Kennedy to Board of Directors
Events
Astarte Medical will be exhibiting at Hot Topics in Neonatology in National Harbor, MD
Please visit us at booth # 301
Astarte Medical will be exhibiting at the Pediatric Academic Societies Meeting in Philadelphia, PA
Please visit us at booth # 810